Company Profile

BioLife Solutions Stock Price, News & Analysis

Ticker:
BLFS
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, BioLife Solutions is followed within the biotech universe for its exposure to catalyst-driven execution.

Stock performance

24.79 USD (-0.44%)

Close

Last updated: June 23, 2026 at 00:00

1.21B USD

Market cap

Why the stock is moving

BLFS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

BioLife Solutions is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, BioLife Solutions is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

BioLife Solutions follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, BioLife Solutions sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of BioLife Solutions (BLFS)?

    BioLife Solutions (BLFS) most recently closed at 24.79 USD, a -0.44% move versus the previous session.

    What is the market cap of BioLife Solutions (BLFS)?

    BioLife Solutions currently has a market capitalization of 1.21B USD on BioPharmSignal.

    What does BioLife Solutions do?

    BioLife Solutions is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    On which exchange is BLFS stock listed?

    BioLife Solutions (BLFS) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, BioLife Solutions is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.

    What is BioLife?

    BioLife Solutions is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

    Which conditions is BioLife Solutions targeting with BioLife?

    BioLife Solutions is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    What is Solutions?

    BioLife Solutions is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

    What is Investors?

    Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.